Search results

ISSUE NO. 6 — Hybrid Medicines and 505(b)(2) NDA Approval Pathways

Dec 1, 2018

• Regulatory Affairs
• End-to-End Program

Scientific Publication

Project and Program Management Services―Clear Oversight at Every Stage

Aug 17, 2026

• CRO Services
• Clinical Trials
• Preclinical Research

Scientific Publication

Flow Cytometry Bioanalysis for Immunomodulation Studies

Jul 23, 2026

• Bioanalysis

Scientific Publication

IND and CTA Submission Principles and Timelines

Jun 16, 2026

• CRO Services

Scientific Publication

Regulatory Pathways by Region―A Comparative Table

Jun 3, 2026

• CRO Services
• Clinical Trials
• Preclinical Research
• Bioanalysis

Scientific Publication

Case Study—Driving Simulator Assessment

Dec 6, 2024

• Clinical Trials

ISSUE NO. 42 — Managing The Complexities of Glucagon-Like Peptide-1 Receptor Agonist Drug Development

Nov 1, 2024

• End-to-End Program
• Preclinical Research
• Clinical Trials
• Bioanalysis